share_log

諾輝健康：截至二零二四年一月三十一日止月份之股份發行人的證券變動月報表

NH HEALTH: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024

香港交易所 ·  Feb 2 05:08
Summary by Moomoo AI
諾輝健康於2024年2月2日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年1月31日的公司股份變動情況。報告顯示，諾輝健康的法定/註冊股本及已發行股份在本月內均無變動，維持在1,000,000,000股普通股，每股面值0.00005美元，總股本為50,000美元。此外，公司於2022年6月24日採納的股份期權計劃及受限制股份單位計劃，本月內均無新股份發行。報告還提到，公司於2023年6月至10月期間購回的股份總數為9,058,500股，但截至報告期末尚未註銷。諾輝健康確認，所有證券發行均已獲董事會批准，並符合香港聯合交易所有限公司證券上市規則的相關要求。
諾輝健康於2024年2月2日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年1月31日的公司股份變動情況。報告顯示，諾輝健康的法定/註冊股本及已發行股份在本月內均無變動，維持在1,000,000,000股普通股，每股面值0.00005美元，總股本為50,000美元。此外，公司於2022年6月24日採納的股份期權計劃及受限制股份單位計劃，本月內均無新股份發行。報告還提到，公司於2023年6月至10月期間購回的股份總數為9,058,500股，但截至報告期末尚未註銷。諾輝健康確認，所有證券發行均已獲董事會批准，並符合香港聯合交易所有限公司證券上市規則的相關要求。
Novi Health filed with Hong Kong Trading and Clearing Limited on February 2, 2024 its latest Securities Changes Monthly Report, reporting the changes in the company's shares as of January 31, 2024. The report shows that Novi Health's regulary/registered share capital and issued shares remained unchanged during the month at 1,000,000,000 shares of ordinary shares with a face value of $0.00005 per share and a total share capital of $50,000. In addition, the Company's Share Option Plan and Restricted Share Unit Plan adopted on June 24, 2022, did not issue new shares during the month. The report also noted that the total number of shares repurchased by the company during June to October 2023 was 9,058,500 shares, but as of the end of the reporting period, no write-offs have been made. Novi Health confirms that all securities issues have been approved by the Board of Directors and comply with the relevant requirements of the Listing Rules of the Stock Exchange of Hong Kong Stock Exchange Limited.
Novi Health filed with Hong Kong Trading and Clearing Limited on February 2, 2024 its latest Securities Changes Monthly Report, reporting the changes in the company's shares as of January 31, 2024. The report shows that Novi Health's regulary/registered share capital and issued shares remained unchanged during the month at 1,000,000,000 shares of ordinary shares with a face value of $0.00005 per share and a total share capital of $50,000. In addition, the Company's Share Option Plan and Restricted Share Unit Plan adopted on June 24, 2022, did not issue new shares during the month. The report also noted that the total number of shares repurchased by the company during June to October 2023 was 9,058,500 shares, but as of the end of the reporting period, no write-offs have been made. Novi Health confirms that all securities issues have been approved by the Board of Directors and comply with the relevant requirements of the Listing Rules of the Stock Exchange of Hong Kong Stock Exchange Limited.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more